INTEGRA student consultants assisted the Mannheim Pharma & Diagnostics GmbH in refining der business model and adapting their pricing strategy. They developed a highly sophisticated and responsive pricing model.
The Mannheim Pharma & Diagnostics GmbH is developing innovative test patches which can make the detection of kidney and liver dysfunctions much cheaper and easier than before. The technology was initially designed for human application but the Mannheim Pharma started to consider animal health as a highly lucrative market with less barriers to entry.
An INTEGRA team consisting of Tobias Regele (project manager), Andreas Schumacher and Franz Joseph Hinzen came in to evaluate the market chances for animal diagnostic patches. To do that, they analyzed the German and US markets for animal health and interviewed a sample of potential clients and veterinarians about their willingness to pay for the product. They also compared the pricing strategies of relevant competitors. At the end, the team created a quantitative pricing model and sensitivity analysis with different scenarios and drew concrete action recommendations for refining the business.
Thanks to the project team for the remarkable results of the project! The high intrinsic motivation and great professionalism of its members should not go unnoticed. Our special thanks goes to INTEGRA for making such great projects possible and to the team for pulling all these all-nighters to be able to come up with this great due diligence and results in such a short period of time.
The project was conducted in Fall Term 2013.